Prognostic and predictive value of KRAS mutations in advanced non-small cell lung cancer.

Clinical implications of KRAS mutations in advanced non-small cell lung cancer remain unclear. We retrospectively evaluated the prognostic and predictive value of KRAS mutations in patients with advanced NSCLC. Among 484 patients with available results for both KRAS and EGFR mutations, 39 (8%) had K...

Full description

Bibliographic Details
Main Authors: Jong-Mu Sun, Deok Won Hwang, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3665805?pdf=render

Similar Items